Jennison Associates
KYMR icon

Jennison Associates’s Kymera Therapeutics KYMR Stock Holding History

Jennison Associates’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.7M Sell
502,978
-6,021
-1% -$517K 0.03% 217
2026
Q1 		$42.4M Buy
508,999
+12,334
+2% +$977K 0.03% 246
2025
Q4 		$38.6M Sell
496,665
-531,074
-52% -$35.9M 0.02% 248
2025
Q3 		$58.2M Buy
1,027,739
+202,714
+25% +$9.14M 0.03% 195
2025
Q2 		$36M Buy
825,025
+272,739
+49% +$9.39M 0.02% 264
2025
Q1 		$15.1M Sell
552,286
-164,647
-23% -$6M 0.01% 356
2024
Q4 		$28.8M Sell
716,933
-80,748
-10% -$3.65M 0.02% 301
2024
Q3 		$37.8M Buy
797,681
+368,394
+86% +$16.3M 0.02% 268
2024
Q2 		$12.8M Buy
429,287
+3,367
+0.8% +$117K 0.01% 362
2024
Q1 		$17.1M Buy
+425,920
New +$15.2M 0.01% 355
2022
Q1 		– Sell
-182,326
Closed -$11.6M – 675
2021
Q4 		$11.6M Sell
182,326
-2,255
-1% -$131K 0.01% 430
2021
Q3 		$10.8M Sell
184,581
-2,120
-1% -$123K 0.01% 442
2021
Q2 		$9.05M Hold
186,701
– – 0.01% 470
2021
Q1 		$7.25M Buy
186,701
+117,346
+169% +$7.06M 0.01% 447
2020
Q4 		$4.3M Sell
69,355
-669
-1% -$32.6K ﹤0.01% 467
2020
Q3 		$2.26M Buy
+70,024
New +$2.14M ﹤0.01% 477

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jennison Associates's KYMR Position: Q2 2026 in Review

Jennison Associates reduced its Kymera Therapeutics (KYMR) stake by 1.2% in Q2 2026, selling an estimated $517K and leaving 502,978 shares worth $57.7M. The position accounts for 0.03% of the portfolio, ranked #217.

Jennison Associates first reported a position in KYMR in Q3 2020 and has held it in 16 quarters since. The position peaked at $58.2M in Q3 2025. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Jennison Associates held 502,978 shares of Kymera Therapeutics worth $57.7M as of Q2 2026.
  • Jennison Associates sold 6,021 Kymera Therapeutics shares in Q2 2026, an estimated $517K.
  • Kymera Therapeutics made up 0.03% of Jennison Associates's portfolio in Q2 2026, its #217 holding.
  • Jennison Associates first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 16 quarters since.
  • Jennison Associates's Kymera Therapeutics position peaked at $58.2M in Q3 2025.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.